Clinical Trials

The Clinical Trials Division of Concorde Medical Group has extensive experience in successfully conducting a wide range of clinical research trials at its Kips Bay Office, centrally located in mid-town Manhattan. The Clinical Trials Division operates within Concorde’s active multi-specialty practice, providing its patients with early access to breakthroughs in medical technologies, treatments and pharmaceuticals.

We are currently enrolling for the following clinical trials:

  • Ulcerative Colitis
  • Crohn’s Disease
  • Clostridium Difficle
  • Non-Alcoholic Steato Hepatitis (NASH/Fatty Liver Disease)
  • Celiac Disease
  • Primary Biliary Cholangitis
  • SIBO-NASH

Registry studies for:

  • Calprotectin
  • Fatty Liver Disease
  • HUMIRA – Ulcerative Colitis Patients ONLY
  • Short Bowel Syndrome

If you have a question about our Clinical Trials Program, contact us by email at clinical-trials@concordemed.com or contact us directly at (212) 889-5544.

Clinical Trials Eligibility?

If you have a question about our Clinical Trials Program, contact us by email at clinical-trials@concordemed.com or contact us directly at (212) 726-9472.

Communication

Contact Us

Quick Contact

  • This field is for validation purposes and should be left unchanged.


Convenience

Our NYC Locations

232 East 30 Street
New York, NY 10016

233 Broadway
Suite 840
New York, NY 10279

100 Crosby Street
Suite 406
New York, NY 10012